EDITORIAL: Evidence‐based management of oropharyngeal cancer

A. Robson,V. Paleri
DOI: https://doi.org/10.1111/j.1749-4486.2010.02159.x
IF: 2.729
2010-08-01
Clinical Otolaryngology
Abstract:The 9th Newcastle evidence-based day on head and neck cancer was planned to focus on squamous cell carcinoma of the oropharynx for several reasons. In the United Kingdom, Cancer Research UK has reported a 51% increase in oral and oropharyngeal squamous cell carcinoma in men from 7 per 100 000 to 11 per 100 000 between 1989 and 2006. In addition, recent studies into the pathogenesis of these tumours and paradigm changes to the management have taken place in the last decade. The meeting covered topics on the pathogenesis, diagnosis and the outcome of treatment of oropharyngeal cancers, with special reference to the role of human papilloma virus (HPV) in the above. Along the lines of the previous meetings, the topics were identified after consultation with senior clinicians across the country. The speakers were asked to undertake a comprehensive review of the topic and dispassionately present their conclusions, and report levels of evidence graded as per the Scottish Intercollegiate Guidelines Network recommendations (http://www.sign.ac.uk/guide lines/fulltext/50/annexb.html). Being of multidisciplinary interest, this meeting was endorsed by the British Association of Head and Neck Oncologists and the British Associations of Otolaryngologists-Head and Neck Surgeons. This year also saw the addition of an invited overseas speaker, Professor Randall Weber from the MD Anderson Cancer Centre, Texas, who discussed at length the evolution of management of oropharyngeal cancer to current day practice. This article summarises the conclusions generated from each presentation and lists the key references.
What problem does this paper attempt to address?